|
The Indian Journal of Pharmacology (ISSN 0253-7613) is an official publication of the Indian Pharmacological Society. The first issue of the journal came out in 1969 and in 1997 it was published Bimonthly.
IJP publishes original research articles, reviews, research letters and correspondences.
More about the journal
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data
The journal is indexed with, or included in, the following:
EMBASE/ Excerpta Medica, Indian Science Abstracts, IndMed, MedInd, MEDLINE/Index Medicus, PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded, Web of Science
Impact Factor® as reported in the 2021 Journal Citation Reports® (Clarivate Analytics, 2022): 2.833
The 5 year Impact Factor of IJP is 2.237
|
|
Current Issue:
November-December 2022 | Vol 54 | Issue
6 
| Editorial |
|
| Translational research: Bridging the gap between preclinical and clinical research |
|
 |
|
| Vidya Mahalmani, Shweta Sinha, Ajay Prakash, Bikash Medhi |
|
|
Drug discovery and development are lengthy and expensive process that takes nearly 10–15 years with an average amount of more than $1–2 billion for the approval of every novel drug for c... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
| |
| Original Research Article |
|
| Lasmiditan abortive therapy for episodic migraine in Phase II/III randomized clinical trials: A meta-analysis |
|
 |
|
| Marya Ahsan, Ayaz Khurram Mallick |
|
|
OBJECTIVE: Although migraine is common, there are very few treatment options. Recently, lasmiditan, a specific 5-HT1F agonist, has gained approval as abortive therapy for migraine.... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
|
| |
| Original Research Article |
|
| Use of drugs not listed in the National List of Essential Medicines: Findings from a prescription analysis by the Indian Council of Medical Research-Rational Use of Medicines Centres Network in tertiary care hospitals across India |
|
 |
|
| Ratinder Jhaj, Aditya Banerjee, Nilima Arun Kshirsagar, Balakrishnan Sadasivam, Sujith J Chandy, Heber Rew Bright, Preetha Kaur Chugh, CD Tripathi, Dinesh Kumar Badyal, Madhulika Peter Samuel, Bikash Medhi, Ajay Prakash, Rupa Joshi, Sandhya Kamat, Raakhi Tripathi, Urwashi Indrakumar Parmar, Harihar Dikshit, Hitesh Mishra, Sukalyan Saha Roy, Niyati Trivedi, Janki Chauhan, Suparna Chatterjee, Manjari Bhattacharya, Chetna K Desai, Shamil Sheth, Pooja Gupta, Atanu Roy, Ramasamy Raveendran, Jayanthi Mathaiyan, G Jeevitha, Sandeep Kaushal, Kanchan Gupta, Samriti Jain, Rajni Kaul |
|
|
BACKGROUND: The concept of listing essential medicines can lead to improved supply and access, more rational prescribing, and lower costs of drugs. However, these benefits hinge on the prescr... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
| Read more.... |
|
|
